159 related articles for article (PubMed ID: 36858904)
1. A blended model to support brief interventions in primary care: A qualitative study of usability and acceptability of HealthEir in community pharmacy.
Sweeney FF; Flynn SM; Ludlow A; Dillon N; Ennis M; Argent R; Kelly S; Mellon L; De Brún A; Hanratty M; Moriarty F; Flood M
Res Social Adm Pharm; 2023 May; 19(5):807-820. PubMed ID: 36858904
[TBL] [Abstract][Full Text] [Related]
2. Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies.
Rao D; Ford JH; Shiyanbola OO
Addict Sci Clin Pract; 2024 Apr; 19(1):27. PubMed ID: 38589965
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
4. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators experienced in delivering alcohol screening and brief interventions in community pharmacy: a qualitative evidence synthesis.
Smith A; Buchanan R; Parkes J; Stone H; Tan QY; Ibrahim K
Int J Pharm Pract; 2024 Feb; 32(1):5-20. PubMed ID: 37936557
[TBL] [Abstract][Full Text] [Related]
6. Feasibility, accessibility and acceptability a pharmacist-led ear health intervention at rural community pharmacies (LISTEN UP): a mixed-methods study in Queensland, Australia.
Taylor S; Cairns A; Glass BD
BMJ Open; 2022 Apr; 12(4):e057011. PubMed ID: 35365533
[TBL] [Abstract][Full Text] [Related]
7. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework.
Murry LT; Keller MS; Pevnick JM; Schnipper JL; Kennelty KA;
BMC Health Serv Res; 2022 Feb; 22(1):186. PubMed ID: 35151310
[TBL] [Abstract][Full Text] [Related]
8. Improving medicines management for people with dementia in primary care: a qualitative study of healthcare professionals to develop a theory-informed intervention.
Barry HE; Bedford LE; McGrattan M; Ryan C; Passmore AP; Robinson AL; Molloy GJ; Darcy CM; Buchanan H; Hughes CM
BMC Health Serv Res; 2020 Feb; 20(1):120. PubMed ID: 32059718
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
[TBL] [Abstract][Full Text] [Related]
10. Co-development and testing of an extended community pharmacy model of service delivery for managing osteoarthritis: protocol for a sequential, multi-methods study (PharmOA).
Babatunde OO; Cottrell E; White S; Chudyk A; Healey EL; Edwards J; Nicholls E; O'Brien N; Todd A; Walker C; Stanford C; Cork T; Long A; Simkins J; Mallen CD; Dziedzic K; Holden MA
BMC Musculoskelet Disord; 2024 Jan; 25(1):54. PubMed ID: 38216895
[TBL] [Abstract][Full Text] [Related]
11. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.
Hindi AMK; Schafheutle EI; Jacobs S
BMC Fam Pract; 2019 Feb; 20(1):26. PubMed ID: 30736732
[TBL] [Abstract][Full Text] [Related]
13. The feasibility and acceptability of the provision of alcohol screening and brief advice in pharmacies for women accessing emergency contraception: an evaluation study.
Brown S; Henderson E; Sullivan C
BMC Public Health; 2014 Nov; 14():1139. PubMed ID: 25369791
[TBL] [Abstract][Full Text] [Related]
14. Improving pharmacy practice in relation to complementary medicines: a qualitative study evaluating the acceptability and feasibility of a new ethical framework in Australia.
Popattia AS; Hattingh L; La Caze A
BMC Med Ethics; 2021 Jan; 22(1):3. PubMed ID: 33407396
[TBL] [Abstract][Full Text] [Related]
15. A user-centered evaluation of medication therapy management alerts for community pharmacists: Recommendations to improve usability and usefulness.
Snyder ME; Adeoye-Olatunde OA; Gernant SA; DiIulio J; Jaynes HA; Doucette WR; Russ-Jara AL
Res Social Adm Pharm; 2021 Aug; 17(8):1433-1443. PubMed ID: 33250363
[TBL] [Abstract][Full Text] [Related]
16. Patient and prescriber perceptions of depression screening within a community pharmacy setting.
Mospan CM; Gillette C; Wilson JA
J Am Pharm Assoc (2003); 2020; 60(5S):S15-S22. PubMed ID: 32280022
[TBL] [Abstract][Full Text] [Related]
17. A qualitative case study of ehealth and digital literacy experiences of pharmacy staff.
MacLure K; Stewart D
Res Social Adm Pharm; 2018 Jun; 14(6):555-563. PubMed ID: 28690128
[TBL] [Abstract][Full Text] [Related]
18. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
[TBL] [Abstract][Full Text] [Related]
19. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.
Steed L; Sohanpal R; Todd A; Madurasinghe VW; Rivas C; Edwards EA; Summerbell CD; Taylor SJ; Walton RT
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011207. PubMed ID: 31808563
[TBL] [Abstract][Full Text] [Related]
20. Pharmacists views on participating in New Zealand's community pharmacy anticoagulation management service: a mixed-methods study.
Beyene K; Chan AHY; Barton E; Yan S; Singh S; Basani A; Voong J; Harrison J
Int J Clin Pharm; 2021 Feb; 43(1):251-262. PubMed ID: 32920685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
